Emmessar Biotech & Nutrition Limited (BOM:524768)
India
· Delayed Price · Currency is INR 32.00
+0.36 (1.14%)
At close: Jul 1, 2025
BOM:524768 Income Statement
Financials in millions INR. Fiscal year is April - March.
Millions INR. Fiscal year is Apr - Mar.
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | 2016 - 2020 |
|---|---|---|---|---|---|---|
Period Ending | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 | Mar '21 Mar 31, 2021 | 2016 - 2020 |
Operating Revenue | 6.11 | 5.55 | 10.19 | 3.65 | 69.91 | Upgrade
|
Other Revenue | 20.09 | 14.86 | 14.96 | 14.08 | 14.66 | Upgrade
|
| 26.2 | 20.42 | 25.15 | 17.73 | 84.56 | Upgrade
| |
Revenue Growth (YoY) | 28.31% | -18.82% | 41.83% | -79.03% | 77.89% | Upgrade
|
Cost of Revenue | 1.82 | 2 | 4.34 | 1.35 | 35.32 | Upgrade
|
Gross Profit | 24.38 | 18.42 | 20.81 | 16.38 | 49.24 | Upgrade
|
Selling, General & Admin | 9.29 | 10.06 | 8.71 | 8.02 | 6.38 | Upgrade
|
Other Operating Expenses | 4.52 | 4.15 | 3.86 | 2.57 | 19.73 | Upgrade
|
Operating Expenses | 14.79 | 15.18 | 13.5 | 11.52 | 26.7 | Upgrade
|
Operating Income | 9.59 | 3.24 | 7.31 | 4.86 | 22.55 | Upgrade
|
Interest Expense | -0.01 | - | - | - | - | Upgrade
|
Interest & Investment Income | - | 4.9 | 2.41 | 2.09 | - | Upgrade
|
Currency Exchange Gain (Loss) | - | -0.02 | -0.05 | -0.09 | - | Upgrade
|
Other Non Operating Income (Expenses) | - | -0 | - | - | - | Upgrade
|
EBT Excluding Unusual Items | 9.58 | 8.12 | 9.67 | 6.87 | 22.55 | Upgrade
|
Gain (Loss) on Sale of Investments | - | 0.01 | 0 | - | - | Upgrade
|
Pretax Income | 9.58 | 8.13 | 9.67 | 9.32 | 22.55 | Upgrade
|
Income Tax Expense | 6.42 | 0.63 | 4.63 | 4.56 | 8.05 | Upgrade
|
Net Income | 3.16 | 7.5 | 5.04 | 4.75 | 14.5 | Upgrade
|
Net Income to Common | 3.16 | 7.5 | 5.04 | 4.75 | 14.5 | Upgrade
|
Net Income Growth | -57.83% | 48.79% | 5.97% | -67.21% | 92.35% | Upgrade
|
Shares Outstanding (Basic) | 5 | 5 | 5 | 5 | 5 | Upgrade
|
Shares Outstanding (Diluted) | 5 | 5 | 5 | 5 | 5 | Upgrade
|
Shares Change (YoY) | 3.72% | - | - | -0.00% | - | Upgrade
|
EPS (Basic) | 0.61 | 1.50 | 1.01 | 0.95 | 2.90 | Upgrade
|
EPS (Diluted) | 0.61 | 1.50 | 1.01 | 0.95 | 2.90 | Upgrade
|
EPS Growth | -59.34% | 48.79% | 5.97% | -67.21% | 92.35% | Upgrade
|
Free Cash Flow | 2.24 | 6.45 | 3.5 | 19.64 | 4.66 | Upgrade
|
Free Cash Flow Per Share | 0.43 | 1.29 | 0.70 | 3.93 | 0.93 | Upgrade
|
Gross Margin | 93.06% | 90.21% | 82.75% | 92.38% | 58.23% | Upgrade
|
Operating Margin | 36.60% | 15.86% | 29.07% | 27.43% | 26.66% | Upgrade
|
Profit Margin | 12.07% | 36.72% | 20.03% | 26.81% | 17.14% | Upgrade
|
Free Cash Flow Margin | 8.54% | 31.57% | 13.91% | 110.78% | 5.51% | Upgrade
|
EBITDA | 10.56 | 4.21 | 8.25 | 5.79 | 23.12 | Upgrade
|
EBITDA Margin | 40.33% | 20.64% | 32.79% | 32.64% | 27.34% | Upgrade
|
D&A For EBITDA | 0.98 | 0.98 | 0.94 | 0.92 | 0.58 | Upgrade
|
EBIT | 9.59 | 3.24 | 7.31 | 4.86 | 22.55 | Upgrade
|
EBIT Margin | 36.60% | 15.86% | 29.07% | 27.43% | 26.66% | Upgrade
|
Effective Tax Rate | 67.01% | 7.75% | 47.89% | 48.96% | 35.70% | Upgrade
|
Revenue as Reported | 26.2 | 25.47 | 27.7 | 22.84 | 84.56 | Upgrade
|
Advertising Expenses | - | 0.22 | 0.17 | 0.17 | - | Upgrade
|
Source: S&P Global Market Intelligence. Standard template. Financial Sources.